Association of IL4 (Rs2243250) Gene Variant and Mycoplasma Pneumoniae Infection with Asthma Susceptibility in an Iraqi Population
Cellular Physiology and Biochemistry · 2025
DOI: 10.33594/000000778 ↗At a glance
Journal article in Cellular Physiology and Biochemistry, 2025. Written by Sarah Kassab Shandaway Al-Zamali and 4 co-authors. Institution: Department of Medical Microbiology, Hammurabi College of Medicine, University of Babylon, Hillah, Babylon, Iraq, ham114.sarah.kassab@uobabylon.edu.iq. Major MEDLINE topics: Asthma, Interleukin-4, Pneumonia, Mycoplasma, Genetic Predisposition to Disease.
Abstract (original language)
Background/Aims: Asthma is a multifactorial disease influenced by both genetic and environmental factors. This study aimed to investigate the association between the IL4 gene polymorphism (rs2243250) and asthma susceptibility, along with serum IL-4 levels. Additionally, it explored Mycoplasma pneumoniae infection as a potential risk factor for asthma.
Methods
A total of 118 individuals were enrolled, including 60 asthma patients and 58 healthy controls. Genotyping for IL4 rs2243250 was performed using allele-specific PCR (AS-PCR). Previous Mycoplasma pneumoniae infection was assessed serologically, and serum IL-4 levels were measured using ELISA.
Results
No significant differences were observed between groups in terms of age, sex, or residence. Smoking (OR: 7.85, P = 0.001) and family history of asthma (OR: 5.33, P = 0.004) were identified as significant risk factors. Mycoplasma pneumoniae infection was significantly more prevalent in asthma patients (41.7%) than in controls, with a strong association with asthma risk (OR: 8.75, P < 0.0001). Genotype frequencies of rs2243250 differed significantly: CC (36.7% vs. 68.9%), CT (41.7% vs. 24.2%), and TT (21.6% vs. 6.9%) in patients versus controls, respectively. The T allele was more frequent among patients (42.5%) than controls (18.97%), increasing asthma risk (OR: 3.16, P = 0.0001). Both CT (OR: 3.25) and TT (OR: 5.91) genotypes were strongly associated with asthma. Moreover, individuals with the TT genotype had significantly higher serum IL-4 levels (P < 0.001).
Conclusion
The IL4 rs2243250 polymorphism is associated with increased asthma susceptibility and elevated serum IL-4 levels in the Iraqi population. Mycoplasma pneumoniae infection also appears to be a significant contributing factor. Larger-scale studies are warranted to confirm these findings and further explore the role of this infection in asthma pathogenesis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Microbiology, Hammurabi College of Medicine, University of Babylon, Hillah, Babylon, Iraq, ham114.sarah.kassab@uobabylon.edu.iq.
- Technical Institute of Babylon, Al-Furat Al-Awsat Technical University (ATU), Iraq.
- Biology Department, College of Science, Al-Qasim Green University, Babylon, Iraq.
- Department of Medical Microbiology, Hammurabi College of Medicine, University of Babylon, Hillah, Babylon, Iraq.
- Department of Clinical Chemistry, Faculty of Medicine Hammurabi, University of Babylon, Babylon, Iraq.
Cite
APA
Al-Zamali, S. K. S., Mohammed, S. S., Radhi, S. H., Hassan, S. A., & Abdulridha, G. A. O. (2025). Association of IL4 (Rs2243250) Gene Variant and Mycoplasma Pneumoniae Infection with Asthma Susceptibility in an Iraqi Population. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000778
Vancouver
Al-Zamali SKS, Mohammed SS, Radhi SH, Hassan SA, Abdulridha GAO. Association of IL4 (Rs2243250) Gene Variant and Mycoplasma Pneumoniae Infection with Asthma Susceptibility in an Iraqi Population. Cellular Physiology and Biochemistry. 2025. doi:10.33594/000000778
BibTeX
@article{AlZamali2025,
author = {Al-Zamali, Sarah Kassab Shandaway and Mohammed, Shahad Saad and Radhi, Safa Hasan and Hassan, Sara Aqeel and Abdulridha, Ghufran Abd Omran},
title = {Association of IL4 (Rs2243250) Gene Variant and Mycoplasma Pneumoniae Infection with Asthma Susceptibility in an Iraqi Population},
journal = {Cellular Physiology and Biochemistry},
year = {2025},
doi = {10.33594/000000778}
}
EUVIMED